Search NASA⌕ Search

SEARCH · Search NASA

Results for “Simulation Radiological Data”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

706 records · Page 40

Motion as a perturbation: Measurement-guided dose estimates to moving patient voxels during modulated arc deliveries

Purpose: To present a framework for measurement-guided VMAT dose reconstruction to moving patient voxels from a known motion kernel and the static phantom data, and to validate this perturbation-based approach with the proof-of-principle experiments. Methods: As described previously, the VMAT 3D dose to a static patient can be estimated by applying a phantom measurement-guided perturbation to the treatment planning system (TPS)-calculated dose grid. The fraction dose to any voxel in the presence of motion, assuming the motion kernel is known, can be derived in a similar fashion by applying a measurement-guided motion perturbation. The dose to the diodes in a helical phantom is recorded at 50 ms intervals and is transformed into a series of time-resolved high-density volumetric dose grids. A moving voxel is propagated through this 4D dose space and the fraction dose to that voxel in the phantom is accumulated. The ratio of this motion-perturbed, reconstructed dose to the TPS dose in the phantom serves as a perturbation factor, applied to the TPS fraction dose to the similarly situated voxel in the patient. This approach was validated by the ion chamber and film measurements on four phantoms of different shape and structure: homogeneous and inhomogeneous cylinders, a homogeneous cube, and an anthropomorphic thoracic phantom. A 2D motion stage was used to simulate the motion. The stage position was synchronized with the beam start time with the respiratory gating simulator. The motion patterns were designed such that the motion speed was in the upper range of the expected tumor motion (1-1.4 cm/s) and the range exceeded the normally observed limits (up to 5.7 cm). The conformal arc plans for X or Y motion (in the IEC 61217 coordinate system) consisted of manually created narrow (3 cm) rectangular strips moving in-phase (tracking) or phase-shifted by 90 Degree-Sign (crossing) with respect to the phantom motion. The XY motion was tested with the computer-derived VMAT MLC sequences. For all phantoms and plans, time-resolved (10 Hz) ion chamber dose was collected. In addition, coronal (XY) films were exposed in the cube phantom to a VMAT beam with two different starting phases, and compared to the reconstructed motion-perturbed dose planes. Results: For the X or Y motions with the moving strip and geometrical phantoms, the maximum difference between perturbation-reconstructed and ion chamber doses did not exceed 1.9%, and the average for any motion pattern/starting phase did not exceed 1.3%. For the VMAT plans on the cubic and thoracic phantoms, one point exhibited a 3.5% error, while the remaining five were all within 1.1%. Across all the measurements (N = 22), the average disagreement was 0.5 {+-} 1.3% (1 SD). The films exhibited {gamma}(3%/3 mm) passing rates {>=}90%. Conclusions: The dose to an arbitrary moving voxel in a patient can be estimated with acceptable accuracy for a VMAT delivery, by performing a single QA measurement with a cylindrical phantom and applying two consecutive perturbations to the TPS-calculated patient dose. The first one accounts for the differences between the planned and delivered static doses, while the second one corrects for the motion.

60 APPLIED LIFE SCIENCES↗

{sup 18}F-FLT uptake kinetics in head and neck squamous cell carcinoma: A PET imaging study

Purpose: To analyze the kinetics of 3{sup ′}-deoxy-3{sup ′}-[F-18]-fluorothymidine (18F-FLT) uptake by head and neck squamous cell carcinomas and involved nodes imaged using positron emission tomography (PET). Methods: Two- and three-tissue compartment models were fitted to 12 tumor time-activity-curves (TACs) obtained for 6 structures (tumors or involved nodes) imaged in ten dynamic PET studies of 1 h duration, carried out for five patients. The ability of the models to describe the data was assessed using a runs test, the Akaike information criterion (AIC) and leave-one-out cross-validation. To generate parametric maps the models were also fitted to TACs of individual voxels. Correlations between maps of different parameters were characterized using Pearson'sr coefficient; in particular the phosphorylation rate-constants k{sub 3-2tiss} and k{sub 5} of the two- and three-tissue models were studied alongside the flux parameters K{sub FLT-2tiss} and K{sub FLT} of these models, and standardized uptake values (SUV). A methodology based on expectation-maximization clustering and the Bayesian information criterion (“EM-BIC clustering”) was used to distil the information from noisy parametric images. Results: Fits of two-tissue models 2C3K and 2C4K and three-tissue models 3C5K and 3C6K comprising three, four, five, and six rate-constants, respectively, pass the runs test for 4, 8, 10, and 11 of 12 tumor TACs. The three-tissue models have lower AIC and cross-validation scores for nine of the 12 tumors. Overall the 3C6K model has the lowest AIC and cross-validation scores and its fitted parameter values are of the same orders of magnitude as literature estimates. Maps ofK{sub FLT} and K{sub FLT-2tiss} are strongly correlated (r = 0.85) and also correlate closely with SUV maps (r = 0.72 for K{sub FLT-2tiss}, 0.64 for K{sub FLT}). Phosphorylation rate-constant maps are moderately correlated with flux maps (r = 0.48 for k{sub 3-2tiss} vs K{sub FLT-2tiss} and r = 0.68 for k{sub 5} vs K{sub FLT}); however, neither phosphorylation rate-constant correlates significantly with SUV. EM-BIC clustering reduces the parametric maps to a small number of levels—on average 5.8, 3.5, 3.4, and 1.4 for K{sub FLT-2tiss}, K{sub FLT}, k{sub 3-2tiss}, and k{sub 5.} This large simplification is potentially useful for radiotherapy dose-painting, but demonstrates the high noise in some maps. Statistical simulations show that voxel level noise degrades TACs generated from the 3C6K model sufficiently that the average AIC score, parameter bias, and total uncertainty of 2C4K model fits are similar to those of 3C6K fits, whereas at the whole tumor level the scores are lower for 3C6K fits. Conclusions: For the patients studied here, whole tumor FLT uptake time-courses are represented better overall by a three-tissue than by a two-tissue model. EM-BIC clustering simplifies noisy parametric maps, providing the best description of the underlying information they contain and is potentially useful for radiotherapy dose-painting. However, the clustering highlights the large degree of noise present in maps of the phosphorylation rate-constantsk{sub 5} and k{sub 3-2tiss}, which are conceptually tightly linked to cellular proliferation. Methods must be found to make these maps more robust—either by constraining other model parameters or modifying dynamic imaging protocols.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data

Purpose: To determine whether the left ventricular ejection fractions (EFs), measured on a high-sensitivity CZT single photon emission computed tomography (SPECT)-camera with a 70% reduction in recording times and a prevention of EF overestimation through an additional count-calibration, are concordant with reference EF from planar radionuclide angiography (2D-RNA). Methods: An additional 10-minute CZT-SPECT recording was performed in patients referred to 2D-RNA for cardiomyopathy (n = 23) or chemotherapy monitoring (n = 50) with an in vivo red blood cell labeling with 850 MBq {sup 99m}TcO{sub 4}{sup −}. The EF, obtained from CZT-SPECT with 100% (SPECT100) or 30% (SPECT30) projection times and with a SPECT-count calibration on the 2D-RNA counts of corresponding cavity volumes, were compared to EF from 2D-RNA. Results: Strong and equivalent relationships were documented between the EF from 2D-RNA and the calibrated EF from SPECT100 (y = 0.89x + 6.62; R{sup 2} = 0.87) and SPECT30 (y = 0.87x + 8.40; R{sup 2} = 0.85), and the mean EF from SPECT100 (54% ± 15%) and SPECT30 (53% ± 16%) were close to that from 2D-RNA (55% ± 15%). However, upward shifts in these mean values were documented in the absence of count calibration for both SPECT100 (60% ± 18%) and SPECT30 (60% ± 18%). Conclusion: Left ventricular EF may be determined on a high-sensitivity CZT-camera, a 70% reduction in injected activities, and an additional count-calibration for further enhancing the concordance with 2D-RNA values. [French] French Abstract: Objectif: Déterminer si les fractions d'éjection ventriculaire gauche (EF) mesurées sur une caméra CZT SPECT à haute sensibilité avec une réduction de 70% des temps d'enregistrement et une prévention de la surestimation de l'EF grâce à un étalonnage supplémentaire des coups concordent avec les EF de référence obtenues par angiographie scintigraphique planaire (2D-RNA). Méthodes: Un enregistrement CZT-SPECT supplémentaire de 10 minutes a été réalisé chez les patients référés pour évaluation de cardiomyopathie (n=23) ou suivi de chimiothérapie (n = 50) par angiographie scintigraphique planaire (2D-RNA) au globules rouges marqués avec 850 MBq 99mTcO4-. Les EF, obtenues au moyen d’une caméra CZT-SPECT avec 100% (SPECT100) ou 30% (SPECT30) de temps d’acquisition et avec étalonnage des coups SPECT sur les images 2D-RNA des volumes de cavité correspondants ont été comparés aux EF à partir de 2D-RNA. Résultats: une corrélation significative existe entre les EF obtenues par 2D-RNA et les EF étalonnées obtenues par SPECT100 (y = 0,89x + 6,62; R2 = 0,87) et SPECT30 (y = 0,87x + 8,40; R2 = 0,85). Les EF moyennes de SPECT100 (54 ± 15%) et SPECT30 (53 ± 16%) sont similaires à celles obtenues par 2D-RNA (55 ± 15%). En l'absence d'étalonnage de comptage des études SPECT100 (60 ± 18%) et SPECT30 (60 ± 18%), ces valeurs moyennes d’EF sont généralement plus élevées. Conclusion: La fonction ventriculaire gauche peut être déterminée avec une caméra CZT à haute sensibilité, une réduction des activités injectées et un étalonnage supplémentaire des coups pour améliorer la concordance avec les valeurs obtenues par 2D-RNA. [Spanish] Spanish Abstract: Propósito: Determinar si la fracción de eyección del ventrículo izquierdo, medida con la cámara CZT-SPECT con una reducción del 70% en tiempo de grabación y con la prevención de la sobreestimación mediante una calibración de cuentas adicional, que sea concordante con el valor referencia de fracción de eyección mediante radiografía planar de radionucleidos. (2D-RNA). Métodos: Una grabación adicional de 10 minutos con CZT-SPECT se realizo en pacientes referidos a radiografía planar de radionucleidos (2D-RNA) por miocardiopatías. (n = 23) o para monitorizar las quimioterapias (n = 50) con marcaje de glóbulos rojos con 850 MBq 99m TcO4. La fracción de eyección obtenida por CZT-SPECT con 100% (SPECT100) o 30% (SPECT30) de tiempo de proyección, y con SPECT con calibración de cuentas con el 2D-RNA, los volúmenes de cavidades fueron comparados con fracción de eyección . Relaciones fuertes y equivalentes fueron documentados entre fracción de eyección del 2D-RNA, y la forma calibrada de la fracción de eyección SPECT100 (y = 0.89x + 6.62; R2 = 0.87) y SPECT30 y = 0.87x + 8.40; R2 = 0.85), y la media de fracción de eyección de SPECT100 (54 ± 15%) and SPECT30 (53 ± 16%) fueron cercanos a la de el 2D-RNA (55 ± 15%). Aunque, aumentos en estas medias se documentaron en la ausencia de la calibración de cuentas para SPECT100 (60 ± 18%) y SPECT30 (60 ± 18%). Conclusión: La fracción de eyección del ventrículo izquierdo puede ser determinada con una cámara CZT de alta sensibilidad, una reducción del 70% en actividades inyectadas y la calibración de cuentas adicional para realzar la concordancia con los valores de 2D-RNA. [Chinese] Chinese Abstract: 目的: 以平面放射性核素血管造影 (2D-RNA) 测定左心室射血分数 (EF) 作为参考标准,为确定利用高灵敏度 CZT SPECT 相机在减少 70% 的记录时间, 并结合计数校准防止高估情况下测量的 EF值, 是否与 2D-RNA 测得的 EF 值一致。 方法: 对心肌病 (n = 23) 或化疗监测 (n = 50) 的患者采用体内标记法注射 850 MBq {sup 99m}TcO{sub 4} 标记的红细胞进行 2D-RNA ,随后再采集 10 分钟 CZT-SPECT。 对 CZT-SPECT 100% 投影时间 (SPECT100) 或 30% 投影时间 (SPECT30) 获得的图像进行重建, 并进行计数校准 (对相应容积获得的 2D-RNA 计数通过 SPECT 校准)获得 EF 值, 与 2D-RNA 测定的 EF 的进行比较。 结果: 2D-RNA 测定的 EF 值与 SPECT100 校准后测定的 EF 值 (y = 0.89x + 6.62; R{sup 2} = 0.87) 及 SPECT30 (y = 0.87x + 8.40; R{sup 2} = 0.85) 校准后 EF 值具有高度相关性, 并且 SPECT100 (54 ± 15%) 和 SPECT30 (53 ± 16%) 测定的 EF 平均值与 2D-RNA 测定的 EF 平均值 (55 ± 15%) 非常接近。 但是, 在没有计数校准的情况下, SPECT100 (60 ± 18%) 和 SPECT30 (60 ± 18%) 测定的 EF 平均值会被高估。 结论: 高灵敏度 CZT 相机可在减少 70% 的注射剂量情况下测定左心室 EF 值, 结合计数校准可进一步提高与 2D-RNA测得的 EF 值的一致性。 关键词: 放射性核素血管造影; 血池 SPECT; CZT 相机; 左心室射血分数; 校准曲线。.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Results of a Geant4 benchmarking study for bio‐medical applications, performed with the G4‐Med system

Geant4, a Monte Carlo Simulation Toolkit extensively used in bio-medical physics, is in continuous evolution to include newest research findings to improve its accuracy and to respond to the evolving needs of a very diverse user community. In 2014, the G4-Med benchmarking system was born from the effort of the Geant4 Medical Simulation Benchmarking Group, to benchmark and monitor the evolution of Geant4 for medical physics applications. The G4-Med system was first described in our Medical Physics Special Report published in 2021. Results of the tests were reported for Geant4 10.5. Purpose In this work, we describe the evolution of the G4-Med benchmarking system. Methods The G4-Med benchmarking suite currently includes 23 tests, which benchmark Geant4 from the calculation of basic physical quantities to the simulation of more clinically relevant set-ups. New tests concern the benchmarking of Geant4-DNA physics and chemistry components for regression testing purposes, dosimetry for brachytherapy with a 125 I source, dosimetry for external x-ray and electron FLASH radiotherapy, experimental microdosimetry for proton therapy, and in vivo PET for carbon and oxygen beams. Regression testing has been performed between Geant4 10.5 and 11.1. Finally, a simple Geant4 simulation has been developed and used to compare Geant4 EM physics constructors and physics lists in terms of execution times. Results In summary, our EM tests show that the parameters of the multiple scattering in the Geant4 EM constructor G4EmStandardPhysics_option3 in Geant4 11.1, while improving the modeling of the electron backscattering in high atomic number targets, are not adequate for dosimetry for clinical x-ray and electron beams. Therefore, these parameters have been reverted back to those of Geant4 10.5 in Geant4 11.2.1. The x-ray radiotherapy test shows significant differences in the modeling of the bremsstrahlung process, especially between G4EmPenelopePhysics and the other constructors under study (G4EmLivermorePhysics, G4EmStandardPhysics_option3, and G4EmStandardPhysics_option4). These differences will be studied in an in-depth investigation within our Group. Improvement in Geant4 11.1 has been observed for the modeling of the proton and carbon ion Bragg peak with energies of clinical interest, thanks to the adoption of ICRU90 to calculate the low energy proton stopping powers in water and of the Linhard–Sorensen ion model, available in Geant4 since version 11.0. Nuclear fragmentation tests of interest for carbon ion therapy show differences between Geant4 10.5 and 11.1 in terms of fragment yields. In particular, a higher production of boron fragments is observed with Geant4 11.1, leading to a better agreement with reference data for this fragment. Conclusions Based on the overall results of our tests, we recommend to use G4EmStandardPhysics_option4 as EM constructor and QGSP_BIC_HP with G4EmStandardPhysics_option4, for hadrontherapy applications. The Geant4-DNA physics lists report differences in modeling electron interactions in water, however, the tests have a pure regression testing purpose so no recommendation can be formulated.

62 RADIOLOGY AND NUCLEAR MEDICINE↗